THOUSAND OAKS, Calif., Sept. 16 /PRNewswire-FirstCall/ -- Amgen
today announced it will present detailed data from four Phase 3 studies as
well as other data at the ECCO 15 - ESMO 34 European Multidisciplinary
Congress, September 20 - 24, 2009 in Berlin, Germany.
